- Corneal Pachymeters
- Optical Coherence Tomography (OCT) Imaging Systems
- Retinal Tomography and Angiography Systems
- Tonometers
- Visual Field Testing Equipment
- Others
Glaucoma Diagnostic Devices Market size was valued at USD 360 million in 2022 and is expected to reach USD 2243 million by 2029, at a CAGR of 28.3% from 2023-2029. Glaucoma is a disease characterized by an increase in the intraocular pressure in the eye that leads to optic nerve damage and causes loss of vision or blindness. The most common types of glaucoma include closed-angle glaucoma and open-angle glaucoma. Glaucoma can be diagnosed by determining the status of the optic nerve, intraocular pressure, and drainage angle. An increase in the geriatric population, escalation in the prevalence rate of glaucoma disease, technological advancements in glaucoma diagnostic devices, and sophisticated healthcare infrastructure in developed countries are expected to fuel the market. However, stringent regulatory guidelines for product approval, high cost of devices, and lack of well-trained professionals in underdeveloped countries may restrain the growth of the market.
Study Period
Base Year
CAGR
Largest Market
Fastest Growing Market
Drivers: High prevalence of glaucoma & rise in geriatric population worldwide. Restraints: Less awareness regarding glaucoma and available surgery devices in underdeveloped economies.
The glaucoma diagnostic devices market size was valued at USD 360 million in 2022
The glaucoma diagnostic devices market key players are: Carl Zeiss Meditec AG (Germany) Topcon Corporation (Japan) Heidelberg Engineering GmbH (Germany) NIDEK CO., LTD (Japan) Optovue, Incorporated (U.S.) Leica Microsystems (Germany) HAAG-STREIT GROUP (U.S.)
The glaucoma diagnostic devices market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.